Shares of Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) were down 1.8% during trading on Tuesday . The company traded as low as $402.14 and last traded at $402.14. Approximately 321 shares changed hands during trading, a decline of 97% from the average daily volume of 9,266 shares. The stock had previously closed at $409.6960.
Roche Trading Up 2.7%
The business’s fifty day moving average price is $376.15 and its 200-day moving average price is $345.81.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
See Also
- Five stocks we like better than Roche
- The Best $1 You’ll Spend This Holiday Season
- Holiday surprise: $1 gets you everything
- Do not delete, read immediately
- America’s “most deplorable” Christmas sale
- Bombshell Exposé on China Strikes
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
